Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study
- PMID: 20722672
- PMCID: PMC3428846
- DOI: 10.1111/j.1464-5491.2010.03056.x
Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study
Abstract
Aims: One of the factors influencing the cost-effectiveness of population screening for Type 2 diabetes may be uptake. We examined attendance and practice- and individual-level factors influencing uptake at each stage of a diabetes screening programme in general practice.
Methods: A stepwise screening programme was undertaken among 135, 825 people aged 40-69 years without known diabetes in 49 general practices in East England. The programme included a score based on routinely available data (age, sex, body mass index and prescribed medication) to identify those at high risk, who were offered random capillary blood glucose (RBG) and glycosylated haemoglobin tests. Those screening positive were offered fasting capillary blood glucose (FBG) and confirmatory oral glucose tolerance tests (OGTT).
Results: There were 33 539 high-risk individuals invited for a RBG screening test; 24 654 (74%) attended. Ninety-four per cent attended the follow-up FBG test and 82% the diagnostic OGTT. Seventy per cent of individuals completed the screening programme. Practices with higher general practitioner staff complements and those located in more deprived areas had lower uptake for RBG and FBG tests. Male sex and a higher body mass index were associated with lower attendance for RBG testing. Older age, prescription of antihypertensive medication and a higher risk score were associated with higher attendance for FBG and RBG tests.
Conclusions: High attendance rates can be achieved by targeted stepwise screening of individuals assessed as high risk by data routinely available in general practice. Different strategies may be required to increase initial attendance, ensure completion of the screening programme, and reduce the risk that screening increases health inequalities.
Figures
Similar articles
-
Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practice.Prim Care Diabetes. 2011 Dec;5(4):265-9. doi: 10.1016/j.pcd.2011.09.001. Epub 2011 Oct 2. Prim Care Diabetes. 2011. PMID: 21968319
-
Screening for type 2 diabetes: literature review and economic modelling.Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. doi: 10.3310/hta11170. Health Technol Assess. 2007. PMID: 17462167 Review.
-
Screening for type 2 diabetes. Lessons from the ADDITION-Europe study.Diabet Med. 2011 Nov;28(11):1416-24. doi: 10.1111/j.1464-5491.2011.03365.x. Diabet Med. 2011. PMID: 21679235
-
Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.Diabetologia. 2004 Sep;47(9):1566-73. doi: 10.1007/s00125-004-1496-2. Epub 2004 Sep 8. Diabetologia. 2004. PMID: 15365615
-
Screening for type 2 diabetes: a short report for the National Screening Committee.Health Technol Assess. 2013 Aug;17(35):1-90. doi: 10.3310/hta17350. Health Technol Assess. 2013. PMID: 23972041 Free PMC article. Review.
Cited by
-
Impact of informed-choice invitations on diabetes screening knowledge, attitude and intentions: an analogue study.BMC Public Health. 2010 Dec 17;10:768. doi: 10.1186/1471-2458-10-768. BMC Public Health. 2010. PMID: 21167033 Free PMC article. Clinical Trial.
-
The influence of non-response in a population-based cohort study on type 2 diabetes evaluated by the Swedish Prescribed Drug Register.Eur J Epidemiol. 2012 Mar;27(3):153-62. doi: 10.1007/s10654-011-9630-1. Epub 2011 Nov 17. Eur J Epidemiol. 2012. PMID: 22089424
-
Noninvasive skin fluorescence spectroscopy for detection of abnormal glucose tolerance.J Clin Transl Endocrinol. 2014 Jul 5;1(3):92-99. doi: 10.1016/j.jcte.2014.06.003. eCollection 2014 Sep. J Clin Transl Endocrinol. 2014. PMID: 29159089 Free PMC article.
-
The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps.Curr Diab Rep. 2019 Mar 2;19(4):18. doi: 10.1007/s11892-019-1133-6. Curr Diab Rep. 2019. PMID: 30826889 Review.
-
Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.Ann Fam Med. 2015 Mar;13(2):149-57. doi: 10.1370/afm.1737. Ann Fam Med. 2015. PMID: 25755036 Free PMC article. Clinical Trial.
References
-
- IDF . The Diabetes Atlas. Fourth Edition Brussels: 2009.
-
- Chang HJ, Kuo HS, Tung TH, Chou P, Chen TH. Evaluation of a population-based screening for type 2 diabetes: a community-based screening project in Puli, Taiwan. Prev Med. 2000 Oct;31(4):396–402. - PubMed
-
- Kuo HS, Chang HJ, Chou P, Teng L, Chen TH. A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM) Int J Epidemiol. 1999 Apr;28(2):233–40. - PubMed
-
- Glumer C, Yuyun M, Griffin S, Farewell D, Spiegelhalter D, Kinmonth AL, et al. What determines the cost-effectiveness of diabetes screening? Diabetologia. 2006 Jul;49(7):1536–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical